Ortho Clinical Diagnostics Holdings PLC News - OCDX

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities Canada NewsWire RARITAN, N.J., Sept. 27...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

false 0001828443 0001828443 2021-09-14 2021-09-14 ...

Ortho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares

RARITAN, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:September 09,

Ortho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary Shares

RARITAN, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s...

Current Report Filing (8-k)

false 0001828443 0001828443 2021-09-07 2021-09-07 ...

Ortho Clinical Diagnostics Announces Secondary Offering of Ordinary Shares

RARITAN, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s...

Securities Registration Statement (s-1)

Table of Contents As filed with the Securities and Exchange Commission on September 7, 2021...

Ortho Clinical Diagnostics to Participate in September Investor Conferences

RARITAN, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Quarterly Report (10-q)

false Q2 0001828443 --01-02 true true P3Y P5Y 0001828443 2021-01-04 2021-07-04 xbrli:shares 0001828443 2021-07-30 iso4217:USD 00...

Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test

Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test Canada...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ortho Clinical Diagnostics Holdings PLC (OCDX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

OCDX News

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Ortho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares

Notice of Effectiveness (effect)

Ortho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary Shares

Current Report Filing (8-k)

Ortho Clinical Diagnostics Announces Secondary Offering of Ordinary Shares

Securities Registration Statement (s-1)

Ortho Clinical Diagnostics to Participate in September Investor Conferences

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Quarterly Report (10-q)

Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test

OCDX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ortho Clinical Diagnostics Holdings PLC (OCDX) News

Ortho Clinical Diagnostics Holdings PLC (OCDX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

OCDX News

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Ortho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares

Notice of Effectiveness (effect)

Ortho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary Shares

Current Report Filing (8-k)

Ortho Clinical Diagnostics Announces Secondary Offering of Ordinary Shares

Securities Registration Statement (s-1)

Ortho Clinical Diagnostics to Participate in September Investor Conferences

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Quarterly Report (10-q)

Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test

OCDX Discussion

Your Recent History